Evidence map›Paper›PMID 41315107›Full record

ArticleMedical & biological engineering & computing2026

A computationally efficient biomedical text processing framework for pharmacovigilance: integrating low-rank adaptation and interpretable AI for adverse drug reaction detection.

Zahra Rezaei, Sara Safi Samghabadi, Mohammad Amin Amini, Yaser Mike Banad

Abstract read
In one paragraph

Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zahra RezaeiSchool of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, 73019, USA.
Sara Safi SamghabadiSchool of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, 73019, USA.
Mohammad Amin AminiSchool of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, 73019, USA.
Yaser Mike BanadSchool of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, 73019, USA. bana@ou.edu.ORCID http://orcid.org/0000-0001-7339-810X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection of adverse drug reactions (ADRs) is crucial for patient safety but remains challenging due to underreporting and delayed data in traditional pharmacovigilance. This study proposes a computationally efficient and interpretable framework for ADR detection by integrating Low-Rank Adaptation (LoRA) and SHapley Additive Explanations (SHAP) with encoder-based transformer models (BERT, DistilBERT, RoBERTa). Leveraging over 3,900 annotated tweets, our approach demonstrates that LoRA reduces trainable parameters and training costs by up to 50%, while preserving high classification accuracy (above 98%) across three disease classes. SHAP analysis provides actionable interpretability, revealing that the models consistently rely on clinically relevant terms, such as drug names and symptoms, to drive predictions. Compared to traditional finetuning, LoRA and Efficient Finetuning of Quantized LLMs (QLoRA) offer a robust and scalable alternative for processing noisy, informal social media data, making real-time ADR monitoring feasible in resource-constrained healthcare settings. This framework strikes a balance between computational efficiency, interpretability, and predictive performance, supporting the integration of pharmacovigilance into clinical decision support systems for safer patient care.

Indexed as

Artificial IntelligenceDrug-Related Side Effects and Adverse ReactionsPharmacovigilanceAdverse Drug Reaction Reporting SystemsAlgorithmsHumansSocial MediaAdverse drug reactionComputational pharmacovigilanceEncoder-only transformersHealthcare information systemsLow-rank adaptation (LoRA)QLoRAShapley additive explanations (SHAP)

Identifiers

PMID41315107
PMCPMC12950037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.